Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03914612 |
|---|---|
| Brief Title: | Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer |
| First Submitted : | April 12, 2019 |
| First Submitted that Met QC Criteria : | April 12, 2019 |
| First Posted : | April 16, 2019 |
| Last Update Submitted that Met QC Criteria : | May 13, 2023 |
| Last Update Posted : | May 16, 2023 |